MetLife Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $50.1M | Sell |
138,472
-5,250
| -4% | -$1.8M | 0.23% | 60 |
|
|
2026
Q1 | $50.6M | Sell |
143,722
-4,488
| -3% | -$1.6M | 0.26% | 49 |
|
|
2025
Q4 | $48.5M | Sell |
148,210
-4,146
| -3% | -$1.32M | 0.23% | 59 |
|
|
2025
Q3 | $43M | Buy |
+152,356
| New | +$44.2M | 0.21% | 70 |
|
|
2025
Q2 | – | Sell |
-157,708
| Closed | -$49.1M | – | 2775 |
|
|
2025
Q1 | $49.1M | Sell |
157,708
-2,967
| -2% | -$876K | 0.27% | 53 |
|
|
2024
Q4 | $41.9M | Buy |
160,675
+1,941
| +1% | +$576K | 0.23% | 62 |
|
|
2024
Q3 | $51.1M | Sell |
158,734
-3,729
| -2% | -$1.22M | 0.29% | 47 |
|
|
2024
Q2 | $50.8M | Buy |
162,463
+22,183
| +16% | +$6.52M | 0.3% | 43 |
|
|
2024
Q1 | $39.9M | Sell |
140,280
-4,594
| -3% | -$1.34M | 0.27% | 55 |
|
|
2023
Q4 | $41.7M | Sell |
144,874
-2,559
| -2% | -$697K | 0.3% | 47 |
|
|
2023
Q3 | $39.6M | Sell |
147,433
-3,326
| -2% | -$830K | 0.31% | 47 |
|
|
2023
Q2 | $33.5M | Sell |
150,759
-4,961
| -3% | -$1.15M | 0.24% | 69 |
|
|
2023
Q1 | $37.6M | Sell |
155,720
-124
| -0.1% | -$30.4K | 0.27% | 59 |
|
|
2022
Q4 | $40.9M | Sell |
155,844
-3,372
| -2% | -$904K | 0.31% | 47 |
|
|
2022
Q3 | $35.9M | Sell |
159,216
-1,722
| -1% | -$417K | 0.3% | 51 |
|
|
2022
Q2 | $39.2M | Sell |
160,938
-11,369
| -7% | -$2.79M | 0.3% | 57 |
|
|
2022
Q1 | $41.7M | Buy |
172,307
+49,280
| +40% | +$11.3M | 0.27% | 62 |
|
|
2021
Q4 | $27.7M | Sell |
123,027
-3,387
| -3% | -$715K | 0.23% | 78 |
|
|
2021
Q3 | $26.9M | Sell |
126,414
-4,928
| -4% | -$1.13M | 0.24% | 78 |
|
|
2021
Q2 | $32M | Sell |
131,342
-4,420
| -3% | -$1.09M | 0.28% | 64 |
|
|
2021
Q1 | $33.8M | Sell |
135,762
-3,731
| -3% | -$890K | 0.31% | 58 |
|
|
2020
Q4 | $32.1M | Sell |
139,493
-7,076
| -5% | -$1.63M | 0.3% | 57 |
|
|
2020
Q3 | $37.3M | Sell |
146,569
-5,988
| -4% | -$1.48M | 0.41% | 41 |
|
|
2020
Q2 | $36M | Sell |
152,557
-602
| -0.4% | -$137K | 0.41% | 41 |
|
|
2020
Q1 | $31M | Sell |
153,159
-4,686
| -3% | -$1.02M | 0.42% | 42 |
|
|
2019
Q4 | $38.1M | Sell |
157,845
-5,356
| -3% | -$1.18M | 0.4% | 43 |
|
|
2019
Q3 | $31.6M | Sell |
163,201
-4,921
| -3% | -$945K | 0.35% | 53 |
|
|
2019
Q2 | $31M | Sell |
168,122
-362,584
| -68% | -$64.9M | 0.33% | 54 |
|
|
2019
Q1 | $101M | Buy |
530,706
+348,472
| +191% | +$66.5M | 0.3% | 56 |
|
|
2018
Q4 | $35.5M | Sell |
182,234
-6,062
| -3% | -$1.18M | 0.43% | 39 |
|
|
2018
Q3 | $39M | Sell |
188,296
-7,759
| -4% | -$1.53M | 0.4% | 41 |
|
|
2018
Q2 | $36.2M | Sell |
196,055
-5,112
| -3% | -$904K | 0.43% | 38 |
|
|
2018
Q1 | $34.3M | Sell |
201,167
-23,436
| -10% | -$4.3M | 0.4% | 43 |
|
|
2017
Q4 | $39.1M | Buy |
+224,603
| New | +$39.7M | 0.44% | 40 |
|
Other funds holding AMGN
MetLife Investment Management's AMGN Position: Q2 2026 in Review
MetLife Investment Management reduced its Amgen (AMGN) stake by 3.7% in Q2 2026, selling an estimated $1.8M and leaving 138,472 shares worth $50.1M. The position accounts for 0.23% of the portfolio, ranked #60.
MetLife Investment Management first reported a position in AMGN in Q4 2017 and has held it in 34 quarters since. The position peaked at $101M in Q1 2019. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- MetLife Investment Management held 138,472 shares of Amgen worth $50.1M as of Q2 2026.
- MetLife Investment Management sold 5,250 Amgen shares in Q2 2026, an estimated $1.8M.
- Amgen made up 0.23% of MetLife Investment Management's portfolio in Q2 2026, its #60 holding.
- MetLife Investment Management first reported a position in Amgen in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's Amgen position peaked at $101M in Q1 2019.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.